MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).

Pre-workout supplements may be helpful for some athletes, but they carry the risk of side effects that may affect your heart, digestion, and more.

Merck on Wednesday said the Phase 3 study of the once-daily, two-drug single-tablet regimen met the success criterion for its primary efficacy hypothesis, showing non-inferiority to the three-drug ...